Rouan Sarah Kathryn 4
4 · Viking Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Award
Common Stock, par value $0.00001 per share
2026-01-02+3,150→ 4,390 total - Award
Stock Option (Right to Buy)
2026-01-02+20,400→ 20,400 totalExercise: $35.42From: 2027-01-02Exp: 2036-01-02→ Common Stock (20,400 underlying)
Footnotes (1)
- [F1]Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. All shares subject to the RSU shall vest on the one year anniversary of the grant date of the award.